Educational material was a topic addressed in the Pharmacovigilance session of the 61st AFI Symposium. Here's what emerged.

One of the various aMMRs is the dissemination of educational material to doctors and patients. Here's how to manage it and who are the actors involved.

AIFA is ready! The Italian Medicines Agency has announced that the new Italian National Pharmacovigilance Network will be available.

As per tradition, the AFI Symposium dedicated a session entirely aimed at pharmacovigilance. Here's what emerged.

After Brexit there were numerous doubts regarding the data flow from EU to UK: in fact, since it is no longer part of the European Union starting from January 2021, it was necessary to find an agreement between the parties, so that European data can circulate safely on British territory.

Complaint management is an activity in which pharmacovigilance and quality can intersect. This was discussed at the AFI webinar “Pharmacovigilance and quality session”, where Recipharma Italia Srl led its example.

Complaint management is a procedure that affects every company, but in the pharmaceutical field, it can also have consequences on the patient's health. Let's see how to handle it.

In the difficult relationship between global and local, KPIs can help for monitoring activities. It was spoken about at the AFI webinar “Pharmacovigilance and quality session”.

The quality system is a fundamental part of pharmacovigilance and is usually in charge of the quality assurance department. How to manage it if there isn't a dedicated staff?

What are the regulations in non-EU countries? And how to manage the requirements between global and local? The answer was given at the EU PhV Congress held on 26th and 27th November of which we were sponsors.

The annual DIA Europe meeting dedicated to the pharmaceutical sector will be held in Vienna from 5th to 7th February 2019: 80 discussion sessions with 300 speakers and more than 35 present Agencies. Here is the program.

During the XI session dedicated to the pharmacovigilance of the 58th AFI Symposium, Mrs. Finizia of GSK spoke about the vaccines, the relative adverse events and vaccinovigilance. Here's what emerged.

The New Esudravigilance System was implemented on 11/22/2017, but the Italian integration with the European database was not painless, said Dr. Sottosanti of AIFA. Here are the latest news.

Biosimilars is a market that has grown considerably in recent years. We talked about it at CPhI 2016 in Barcelona, which we participated in from 4 to 6 October.